clinical trial · NCT05994703
Assisting Smokers to Switch to an e-Cigarette by Accelerating Learning of Adaptive Habits Using D-cycloserine
Rose Research Center, LLC·phase2·completed·n = 25
Smoking CessationHarm Reductiond-cycloserineJuul e-cigarette
brief summary
This study will evaluate the effects of a reward devaluation strategy, which has been researched in the past, combined/augmented with the medication d-cycloserine in assisting smokers to switch from combustible cigarette (CC) to Juul.
started
Oct 20, 2023
primary completion
Oct 13, 2025
completion
Jan 12, 2026
last updated
Jan 20, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol